Pillora - Medication Tracker Mobile App UI Kit V 1.0
- Type
- UI Kit
- Format
- Figma file
- Available on
- Figma
Resource Description
Home, plan and calendar screens with consumed and remaining dose tracking and pill-taking trend insights. Built by the Endpoint Clients design team as a head start for new products. Instead of redrawing the same screens and components every time, start from a clean, consistent base and spend your time on the ideas that make your product different. Open it in Figma, change the styles, and adapt it to your own brand.
Why We Made It
Starting every app from a blank canvas costs days before the real product thinking begins. Teams end up rebuilding common screens, and small inconsistencies creep in as more people join.
Problem 1
Rebuilding the same common screens for every new idea.
Problem 2
Keeping spacing, type and components consistent across a team.
Problem 3
Giving designers and developers one clear, shared starting point.

Solution
A ready-made foundation removes the blank canvas. Common screens, reusable components and shared styles are already in place, so your team starts from something consistent and spends its time on what makes your product different.
Solution 1
Ready-made screens give you the common flows to adapt, instead of redrawing them.
Solution 2
Reusable components and styles keep spacing, type and colour consistent for everyone.
Solution 3
One Figma file gives designers and developers a single, shared starting point.

Style Guide & Component






Wireframe
& UI Design

Workflow Scenario
We started with the structure, laying screens out as simple wireframes before adding colour, type and detail. Each decision was checked against how people would actually use Pillora - Medication Tracker Mobile App UI Kit V 1.0, so the finished design stays clear and consistent from the first screen to the last.
The Result
A faster, cleaner start to your design. Your team begins with a consistent foundation and moves to the part that matters, shaping a product your users want to use.



